ARCHIVES

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 38 | October 6, 1989

Download PDF Visit The Full Archive

Related Articles

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

Cigarette use declining among high school students, report finds.

June 25, 2004

Surgical Oncologists Certification Asked By SSO Workshop

December 9, 1983

IOM Calls For Rapid Reform Of Health Case System.

March 9, 2001

Georgetown Names Cullen Interim Center Director.

November 3, 2000

Obituary: Martin Abeloff, 65, Cancer Center Director At Johns Hopkins.

September 21, 2007